Nasal Continuous Positive Airway Pressure in Bronchiolitis: A Randomized Controlled Trial

Area of Science:

• Pediatrics
• Respiratory Medicine
• Critical Care

Background:

• Bronchiolitis is a common viral respiratory infection in infants, often causing significant respiratory distress.
• Current management primarily focuses on supportive care, with limited interventions proven to effectively alleviate respiratory distress.

Purpose of the Study:

• To evaluate the efficacy of nasal continuous positive airway pressure (nCPAP) in reducing respiratory distress among hospitalized infants diagnosed with bronchiolitis.

Main Methods:

• A randomized controlled trial was conducted involving 72 infants under one year of age hospitalized with bronchiolitis.
• Infants were randomized to receive either standard care or standard care plus nCPAP within the first hour of admission.
• Respiratory rate, Silverman-Anderson score, and Modified Pediatric Society of New Zealand Severity Score were assessed after 60 minutes.

Main Results:

• The nCPAP group showed a significantly greater reduction in respiratory rate (P=0.008) compared to the standard care group.
• Mean changes in Silverman-Anderson score (P=0.029) and Modified Pediatric Society of New Zealand Severity Score (P=0.012) were significantly more favorable in the nCPAP group.
• 14 out of 32 infants in the nCPAP group experienced a respiratory rate change ≥10, versus 5 out of 35 in the standard care group.

Conclusions:

• Nasal continuous positive airway pressure (nCPAP) is an effective intervention for significantly reducing respiratory distress in infants with bronchiolitis.
• The study demonstrates that nCPAP offers a significant advantage over standard care in improving respiratory parameters in this patient population.